{"a":[{"_":"Fierce Pharma Asia—Takeda’s R&D leadership change; Daiichi’s $1.3B court win; New Samsung Bio contract","$":{"href":"/pharma/takeda-rd-leadership-change-daiichi-13b-court-win-new-samsung-bio-contract","hreflang":"en"}}]}

Positive

AI Analysis

Summary

Takeda's R&D chief Andy Plump is retiring, Daiichi Sankyo won a $1.3 billion court case, and Samsung Biologics secured a $262 million contract with an unnamed client.

Importance:4/10

Sentiment:

0.50

leadership_changelitigationcontract_awardR&D

Related Companies

$TAK $DSKYF

Read the original article

Published by FiercePharma on September 11, 2026 9:17 AM

Read Original